Agios Pharmaceuticals, Inc. (AGIO)
32.60
-0.49
(-1.48%)
USD |
NASDAQ |
Aug 24, 16:00
32.33
-0.27
(-0.83%)
After-Hours: 20:00
Agios Pharmaceuticals Shareholders Equity (Quarterly) : 1.026B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.026B |
| March 31, 2026 | 1.109B |
| December 31, 2025 | 1.193B |
| September 30, 2025 | 1.284B |
| June 30, 2025 | 1.370B |
| March 31, 2025 | 1.467B |
| December 31, 2024 | 1.541B |
| September 30, 2024 | 1.627B |
| June 30, 2024 | 660.51M |
| March 31, 2024 | 743.92M |
| December 31, 2023 | 811.02M |
| September 30, 2023 | 886.84M |
| June 30, 2023 | 964.24M |
| March 31, 2023 | 1.037B |
| December 31, 2022 | 1.101B |
| September 30, 2022 | 1.050B |
| June 30, 2022 | 1.124B |
| March 31, 2022 | 1.207B |
| December 31, 2021 | 1.292B |
| September 30, 2021 | 1.395B |
| June 30, 2021 | 1.722B |
| March 31, 2021 | 2.297B |
| December 31, 2020 | 399.50M |
| September 30, 2020 | 480.45M |
| June 30, 2020 | 558.46M |
| Date | Value |
|---|---|
| March 31, 2020 | 625.30M |
| December 31, 2019 | 640.53M |
| September 30, 2019 | 448.29M |
| June 30, 2019 | 532.68M |
| March 31, 2019 | 620.26M |
| December 31, 2018 | 687.54M |
| September 30, 2018 | 760.21M |
| June 30, 2018 | 823.14M |
| March 31, 2018 | 865.59M |
| December 31, 2017 | 375.50M |
| September 30, 2017 | 449.81M |
| June 30, 2017 | 508.99M |
| March 31, 2017 | 307.38M |
| December 31, 2016 | 358.59M |
| September 30, 2016 | 401.45M |
| June 30, 2016 | 289.08M |
| March 31, 2016 | 332.37M |
| December 31, 2015 | 345.12M |
| September 30, 2015 | 375.66M |
| June 30, 2015 | 404.16M |
| March 31, 2015 | 426.82M |
| December 31, 2014 | 424.37M |
| September 30, 2014 | 207.75M |
| June 30, 2014 | 200.55M |
| March 31, 2014 | 121.34M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Biogen, Inc. | 18.85B |
| Insmed, Inc. | 757.49M |
| Liquidia Corp. | 195.11M |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.108B |
| Total Liabilities (Quarterly) | 82.40M |
| Debt to Equity Ratio | 0.0304 |
| Current Ratio | 10.22 |
| Net Debt Paydown Yield | 0.20% |